For the first time, researchers have demonstrated that asymptomatic carotid stenosis may be linked to problems in learning, memory, thinking and decision-making, compared to people with similar risk factors but no carotid stenosis.
Covidien has announced that it has notified customers of a voluntary recall to address an issue with certain lots of its Pipeline embolisation device and Alligator retrieval device where the polytetrafluoroethylene (PTFE) coating applied to the delivery wire could delaminate and detach from the devices.
Elekta, Royal Philips and University Medical Center Utrecht (the Netherlands) announced that the initial components of the world’s first high-field magnetic resonance imaging (MRI) guided radiation therapy system are being installed at University Medical Center Utrecht. According to a company release, this marks a significant milestone toward the development of a clinical system capable of capturing highly detailed MR images of tumours and surrounding normal tissues as a patient receives radiotherapy. Development of the high-field MRI-guided linear accelerator (linac) is the mission of the MR Linac Research Consortium headed by Elekta and supported by Philips.
Brainlab and Mobius Imaging announced CE mark approval for Airo mobile intraoperative computed tomography. The CE mark allows Brainlab to begin installation of the systems sold in the European Union.
At the International Stroke Conference (12–14 February 2014, San Diego, USA) NeuroNews spoke to Javier Romero (director of ultrasound, clinical director of the Neurovascular Laboratory, Massachusetts General Hospital Institute of Heart, Vascular and Stroke Care, Boston, USA) about his poster presentation: “Could CT angiogram be the next screening test for carotid disease? Ultralow radiation for neck CT angiography.” He discussed ultralow radiation as an intermediate imaging tool to bridge the gap between ultrasound and CT angiography
The natural history of patients with proximal large artery occlusions is poor, despite medical treatment. Several clinical and radiographic factors have been shown to be associated with poor outcome including National Insitutes of Health Stroke Scale score (NIHSS)>10, older age, and poor collaterals on computed tomography (CT) angiography. Despite the robust effect of thrombolytic therapy in achieving recanalisation and improving outcome, patients with proximal large artery occlusion have a fair response with relatively low recanalisation rates and poor long-term outcomes. Even with intravenous thrombolysis, the recanalisation rate of proximal middle cerebral artery occlusion was only 20‒50%. This prompted the stroke community to investigate additional therapies to increase recanalisation rates and improve the natural course of this disease
According to AccessClosure, the Mynx Ace is a safe and secure vascular closure device that provides consistent results with a new, easy-to-use deployment system to seal femoral artery access sites. Mynx Ace can be used with patients who have undergone diagnostic or interventional endovascular procedures utilizing a 5-F, 6-F, or 7-F procedural sheath.
Approximately 15 million people worldwide have a stroke every year. Of these, almost 6 million die, while a further 5 million are left permanently disabled. But although stroke is one of the leading causes of death globally, many people remain unaware of the signs and symptoms to look out for, therefore putting their health at risk.
Around 750,000 Americans have a stroke every year. Of these, 5-14% will have a second stroke within 12 months. But new research suggests that if blood pressure is consistently controlled after an initial stroke, the risk of a second one could be reduced by more than 50%.
When someone suffers from a stroke, a silent countdown begins. A fast diagnosis and treatment can mean the difference between life and death. So scientists are working on a new blood test that one day could rapidly confirm whether someone is having a stroke and what kind. Their report appears in the ACS journal Analytical Chemistry.
Individuals suffering from spinal fractures - caused by osteoporosis or weakened bones - now have another option to reduce pain, restore function and improve quality of life, according to a study of 300 patients treated with a new type of vertebral augmentation. Results of a randomized, controlled multicenter trial on a new implant treatment for vertebral compression fractures are being reported for the first time at the Society of Interventional Radiology´s 39th Annual Scientific Meeting.
Scientists have shown that anger, anxiety, and depression not only affect the functioning of the heart, but also increase the risk for heart disease.
Controlling blood pressure, cholesterol and irregular heart rhythms are key to stroke survivors avoiding another stroke.
A new computer program could help doctors predict which patients might suffer potentially fatal side-effects from a key stroke treatment.
In a study that included more than 71,000 stroke patients, implementation of a quality initiative was associated with improvement in the time to treatment and a lower risk of in-hospital death, intracranial hemorrhage (bleeding in the brain), and an increase in the portion of patients discharged to their home, according to the study appearing in JAMA, a neurology theme issue.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos